慢性阻塞性肺病患者的维生素D状态和身体组成的纵向变化 - 一项前性观察性研究
Maria Minter1,2, Jenny van Odijk1, Hanna Augustin1
1Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 405 30, Sweden.
概括
慢性阻塞性肺病 (COPD) 患者的维生素D水平较低,但不会随着时间的推移影响身体组成的变化. 维生素D不足和低骨矿物质密度在COPD患者中更常见.
科学领域:
- 肺部医学 肺部医学
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,体重和身体组成的变化很普遍,影响了发病率和死亡率.
- 低维生素D状态在COPD患者中很常见,与肺功能减弱和肌肉缩有关.
- 这项研究研究了COPD患者的维生素D水平和身体组成之间的关系.
研究的目的:
- 为了评估维生素D水平和状态与COPD患者的身体组成 (BC) 之间的关联.
- 评估维生素D如何影响随着时间的推移改变身体成分.
- 为了比较COPD患者和对照者的维生素D状态和身体成分.
主要方法:
- 包括COPD患者和对照组在内的前性观察研究 (ICE-Age).
- 在基线测量血25-氧维生素D (25(OH) D.
- 在基线和两年后,通过双能X射线吸收计评估的身体组成 (BC).
主要成果:
- 慢性肺炎患者的维生素D水平明显低于对照组 (64 ± 26 nmol/L vs. 75 ± 25 nmol/L).
- 这两组在两年内都显示出无脂肪质量指数 (FFMI) 和部T-score的下降.
- 维生素D水平或状态与两组人体组成或其变化无关.
结论:
- 维生素D状况与身体组成或身体组成的纵向变化无关.
- 与对照组相比,COPD患者的维生素D缺乏和骨矿物质密度 (BMD) 低的情况更为普遍.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


